Jagath Reddy Junutula, our Vice President of Antibody Discovery & Development, joined Cellerant in April 2014. Dr. Junutula brings with him more than 20 years of experience spanning oncology target discovery, antibody engineering, protein engineering and cell biology. He is a recognized expert in antibody drug conjugate (ADC) development and most recently spent over 10 years at Genentech, Inc., where he led cross-functional R&D teams in both ADC and bi-specific antibody-based cancer immunotherapeutic programs in the Discovery Oncology, Research and Early Development Division. Dr. Junutula conducted his post-doctoral training at Stanford University and Genentech. Dr. Junutula received his Ph.D. in biochemistry from the Indian Institute of Science, Bangalore, India.